This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Advancing today’s therapies to enable healthier lives
We are transforming patient care by developing innovative medicines that address significant unmet patient needs in high-value markets
Proprietary portfolio
Using our Arestat™ technology platform, we are developing enhanced therapeutic medicines for the treatment of diabetes and obesity
Partnering
We are partnering with leading pharmaceutical and medtech companies to develop enhanced therapeutic medicines
Validated technology
A business underpinned by the world-leading Arestat™ technology platform with a robust intellectual property portfolio
Latest News
-
19th May 2025
ARECOR ESTABLISHES PARTNERSHIP WITH SKYE BIOSCIENCE TO DEVELOP ENHANCED FORMULATION OF OBESITY CANDIDATE NIMACIMAB
-
8th May 2025
ARECOR SELLS RIGHTS TO NON-OGLUO® PRODUCTS
-
26th March 2025
ARECOR ENTERS COLLABORATION WITH MAJOR GLOBAL PHARMACEUTICAL PARTNER